Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients.
Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
The determinants of depression in a Romanian cohort of multiple sclerosis patients.
Palliative treatment of chronic neurologic disorders.
A comparative study of magnetic resonance venography techniques for the evaluation of the internal jugular veins in multiple sclerosis patients.
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.
Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab.
Multiple sclerosis: relapses, resource use, and costs.
Systematic review of correlates and determinants of physical activity in persons with multiple sclerosis.
The many faces of impaired bladder emptying.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors.
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
Internal jugular veins out flow in patients with multiple sclerosis:a catheter venography study.
B-mode transorbital ultrasononography for the diagnosis of acute optic neuritis. A systematic review.
Cancer drug shows promise for multiple sclerosis.
[MR imaging of multiple sclerosis].
The development of primary central nervous system B-cell lymphoma in multiple sclerosis.
Pages
« first
‹ previous
…
569
570
571
572
573
574
575
576
577
…
next ›
last »